Starbucks Learned Its Airport Customers Have Different Needs. It Developed a Strategy Anyone Can Copy From
While the brand remains the same, the customers were looking for a different experience.
Similar Posts
Reed bill seeks clearer federal insider trading rules
Key takeaway: The bill, dubbed the Insider Trading Prohibition Act, would clearly define insider trading. Expert quote: “This legislation provides a clear definition of insider trading, with appropriate safety valves, that will help protect the investing public.” — Sen. Jack Reed, D-R.I. What’s at stake: There is no standalone federal statute specifically banning insider trading. Instead,…
Help not wanted: World Cup hiring boost has yet to materialize
The hiring boom the FIFA World Cup was expected to bring to the US looks like it may not end up materializing after all. Ahead of the June 11 kickoff of the soccer tournament, the first in the US since 1994, FIFA predictedthe events could create the equivalent of 185,000 full-time jobs, primarily in leisure and…
Warsh welcomes yield spikes as ‘change for the better’
Key insight: Federal Reserve Chair Kevin Warsh hailed rising market interest rates between Federal Open Market Committee meetings as a positive development. Expert quote: “Market participants are learning to play the ball, not the referee, and market prices will continue to respond in the direction and magnitude they see fit. This is, in my view,…
TabaPay is seeking to buy a community bank for its charter
Key insight: TabaPay is seeking to acquire a bank charter and deposit insurance through filing to purchase a small community bank. Expert Quote: “Mature fintechs are increasingly asking whether it makes sense to own more of the banking stack themselves.” West Monroe’s Tom Collins Forward Look: The company expects to close on the deal later…
Argenx Just Landed Another Phase 3 Win — and Wall Street May Be Missing the Bigger Story
Argenx (ARGX +0.83%) already markets Vyvgart Hytrulo for treating generalized myasthenia gravis (gMG) and chronic inflammatory demyelinating polyneuropathy (CIDP), two rare chronic autoimmune diseases. It appears to be on track to add another approved indication for the drug. On Aug. 17, 2026, Argenx announced positive results from a Phase 3 clinical study evaluating Vyvgart Hytrulo…
Your Retirement Budget After 75: What Drops and What Doesn’t
FG Trade / Getty Images Commitment to Our Readers GOBankingRates’ editorial team is committed to bringing you unbiased reviews and information. We use data-driven methodologies to evaluate financial products and services – our reviews and ratings are not influenced by advertisers. You can read more about our editorial guidelines and our products and services review…
